한글목차

개요

여행용 백신 시장은 2023-2028년간 39억 7,000만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 8.64%를 나타낼 것으로 예측됩니다.

여행용 백신 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 세계적인 이민 증가, 여행자 백신으로 예방 가능한 질병에 대한 의식 고양, 비자 발급전 예방 접종에 관한 규제 의무화 등이 시장 성장을 가속하고 있습니다.

본 조사에서는 향후 몇 년간 여행용 백신 시장 성장을 가속하는 주요 요인으로서 세계의 여행자 인구통계 변화를 들고 있습니다. 여행에 관련된 질병 발생률 증가, 여행의 안전성을 확보하기 위한 정부나 기타 조직의 대처 또한 시장의 높은 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 여행용 백신 시장(2018-2022년)
• 병 유형별 부문 분석(2018-2022년)
• 최종사용자별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 질환 유형별

• 시장 부문
• 비교 : 질환 유형별
• 인플루엔자 : 시장 규모와 예측(2023-2028년)
• 디프테리아 : 시장 규모와 예측(2023-2028년)
• 간염 : 시장 규모와 예측(2023-2028년)
• 장티푸스 및 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 질환 유형별

제7장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 성인용 백신 : 시장 규모와 예측(2023-2028년)
• 소아용 백신 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 최종사용자별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Abbott Laboratories
• AstraZeneca Plc
• Bharat Biotech Ltd.
• CSL Ltd.
• Dynavax Technologies Corp.
• GlaxoSmithKline Plc
• KM Biologics Co. Ltd.
• LG Chem Ltd.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Serum Institute of India Pvt. Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Valneva SE

제13장 부록

영문목차

Abstract

The travel vaccines market is forecasted to grow by USD 3.97 bn during 2023-2028, accelerating at a CAGR of 8.64% during the forecast period. The report on the travel vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in global migration, increase in awareness of vaccine-preventable diseases among travelers, and mandatory regulations on immunization prior to issuing visas.

Technavio's travel vaccines market is segmented as below:

By Disease Type

• Influenza
• Diptheria
• Hepatitis
• Typhoid and others

By End-user

• Adult vaccines
• Pediatric vaccines

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the changes in demographic profile of travelers globally as one of the prime reasons driving the travel vaccines market growth during the next few years. Also, increased incidence of travel-related diseases and initiatives by governments and other organizations to ensure travel safety will lead to sizable demand in the market.

The report on the travel vaccines market covers the following areas:

• Travel vaccines market sizing
• Travel vaccines market forecast
• Travel vaccines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading travel vaccines market vendors that include Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the travel vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global travel vaccines market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global travel vaccines market 2018 - 2022 ($ billion)
• 4.2 Disease Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Disease Type

• 6.1 Market segments
• Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)
• 6.2 Comparison by Disease Type
• Exhibit 32: Chart on Comparison by Disease Type
• Exhibit 33: Data Table on Comparison by Disease Type
• 6.3 Influenza - Market size and forecast 2023-2028
• Exhibit 34: Chart on Influenza - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Influenza - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Influenza - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Influenza - Year-over-year growth 2023-2028 (%)
• 6.4 Diptheria - Market size and forecast 2023-2028
• Exhibit 38: Chart on Diptheria - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Diptheria - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Diptheria - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Diptheria - Year-over-year growth 2023-2028 (%)
• 6.5 Hepatitis - Market size and forecast 2023-2028
• Exhibit 42: Chart on Hepatitis - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Hepatitis - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Hepatitis - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Hepatitis - Year-over-year growth 2023-2028 (%)
• 6.6 Typhoid and others - Market size and forecast 2023-2028
• Exhibit 46: Chart on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Typhoid and others - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Typhoid and others - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by Disease Type
• Exhibit 50: Market opportunity by Disease Type ($ billion)
• Exhibit 51: Data Table on Market opportunity by Disease Type ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 54: Chart on Comparison by End-user
• Exhibit 55: Data Table on Comparison by End-user
• 7.3 Adult vaccines - Market size and forecast 2023-2028
• Exhibit 56: Chart on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Adult vaccines - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Adult vaccines - Year-over-year growth 2023-2028 (%)
• 7.4 Pediatric vaccines - Market size and forecast 2023-2028
• Exhibit 60: Chart on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by End-user
• Exhibit 64: Market opportunity by End-user ($ billion)
• Exhibit 65: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
• Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 115: Abbott Laboratories - Overview
• Exhibit 116: Abbott Laboratories - Business segments
• Exhibit 117: Abbott Laboratories - Key news
• Exhibit 118: Abbott Laboratories - Key offerings
• Exhibit 119: Abbott Laboratories - Segment focus
• 12.4 AstraZeneca Plc
• Exhibit 120: AstraZeneca Plc - Overview
• Exhibit 121: AstraZeneca Plc - Product / Service
• Exhibit 122: AstraZeneca Plc - Key news
• Exhibit 123: AstraZeneca Plc - Key offerings
• 12.5 Bharat Biotech Ltd.
• Exhibit 124: Bharat Biotech Ltd. - Overview
• Exhibit 125: Bharat Biotech Ltd. - Product / Service
• Exhibit 126: Bharat Biotech Ltd. - Key news
• Exhibit 127: Bharat Biotech Ltd. - Key offerings
• 12.6 CSL Ltd.
• Exhibit 128: CSL Ltd. - Overview
• Exhibit 129: CSL Ltd. - Business segments
• Exhibit 130: CSL Ltd. - Key offerings
• Exhibit 131: CSL Ltd. - Segment focus
• 12.7 Dynavax Technologies Corp.
• Exhibit 132: Dynavax Technologies Corp. - Overview
• Exhibit 133: Dynavax Technologies Corp. - Product / Service
• Exhibit 134: Dynavax Technologies Corp. - Key offerings
• 12.8 GlaxoSmithKline Plc
• Exhibit 135: GlaxoSmithKline Plc - Overview
• Exhibit 136: GlaxoSmithKline Plc - Business segments
• Exhibit 137: GlaxoSmithKline Plc - Key news
• Exhibit 138: GlaxoSmithKline Plc - Key offerings
• Exhibit 139: GlaxoSmithKline Plc - Segment focus
• 12.9 KM Biologics Co. Ltd.
• Exhibit 140: KM Biologics Co. Ltd. - Overview
• Exhibit 141: KM Biologics Co. Ltd. - Product / Service
• Exhibit 142: KM Biologics Co. Ltd. - Key offerings
• 12.10 LG Chem Ltd.
• Exhibit 143: LG Chem Ltd. - Overview
• Exhibit 144: LG Chem Ltd. - Business segments
• Exhibit 145: LG Chem Ltd. - Key news
• Exhibit 146: LG Chem Ltd. - Key offerings
• Exhibit 147: LG Chem Ltd. - Segment focus
• 12.11 Merck and Co. Inc.
• Exhibit 148: Merck and Co. Inc. - Overview
• Exhibit 149: Merck and Co. Inc. - Business segments
• Exhibit 150: Merck and Co. Inc. - Key news
• Exhibit 151: Merck and Co. Inc. - Key offerings
• Exhibit 152: Merck and Co. Inc. - Segment focus
• 12.12 Novartis AG
• Exhibit 153: Novartis AG - Overview
• Exhibit 154: Novartis AG - Business segments
• Exhibit 155: Novartis AG - Key offerings
• Exhibit 156: Novartis AG - Segment focus
• 12.13 Pfizer Inc.
• Exhibit 157: Pfizer Inc. - Overview
• Exhibit 158: Pfizer Inc. - Product / Service
• Exhibit 159: Pfizer Inc. - Key news
• Exhibit 160: Pfizer Inc. - Key offerings
• 12.14 Sanofi SA
• Exhibit 161: Sanofi SA - Overview
• Exhibit 162: Sanofi SA - Business segments
• Exhibit 163: Sanofi SA - Key news
• Exhibit 164: Sanofi SA - Key offerings
• Exhibit 165: Sanofi SA - Segment focus
• 12.15 Serum Institute of India Pvt. Ltd.
• Exhibit 166: Serum Institute of India Pvt. Ltd. - Overview
• Exhibit 167: Serum Institute of India Pvt. Ltd. - Product / Service
• Exhibit 168: Serum Institute of India Pvt. Ltd. - Key offerings
• 12.16 Takeda Pharmaceutical Co. Ltd.
• Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.17 Valneva SE
• Exhibit 173: Valneva SE - Overview
• Exhibit 174: Valneva SE - Business segments
• Exhibit 175: Valneva SE - Key offerings
• Exhibit 176: Valneva SE - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 179: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources
• 13.5 List of abbreviations
• Exhibit 183: List of abbreviations